Skip to content

A clinical and experimental study to compare the four types of virechana karma (Purgation Therapy) i.e Anulomana-By Haritaki, Sramsana-By Aragwadha, Bhedana-By Katuki,Rechana-By Trivrit and their efficacy in the management of Ekakushtha (Psoriasis).

A Clinico-Experimental Study on Four Types Of Virechana Karma in Ekakushtha (Psoriasis)

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/04/002583
Enrollment
100
Registered
2012-04-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from psoriasis

Interventions

Intervention1: Terminalia chebula Retz : About 25 -50gms of Terminalia chebula Retz fruit coarse powder is taken and decoction is prepared.About 150-250ml is administered orally once for Virechana (

Sponsors

I P G T R A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with all forms of Psoriasis who are clinically fit to undergo Virechana procedure. 2.Age- 17 to 60 years 3.Sex- Both sexes 4.Patients having Madhyma Koshtha

Exclusion criteria

Exclusion criteria: 1.Clinically unfit for Virechana. 2.Age 60yrs. 3.Patients having Mridu & Krura Koshtha. 4.Pregnant lady 5.Any other serious systemic illness 6.Patient not willing for treatment.

Design outcomes

Primary

MeasureTime frame
Assessment of Virechana -Based on Vaigiki shuddhi , Maniki shuddhi, Laingiki shuddhi and Antiki shuddhi. -Time of administration of Virechana drug & time of onset of first vega. -Total duration of Virechana. -Effect of four types of Virechana on Hematological and bio-chemical parameters. Timepoint: Assessment will be done during the time of Virechana.

Secondary

MeasureTime frame
1.Improvements in signs and symptoms of Psoriasis. 2. Improvements in Dermatology Life Quality Index. 3.Improvements in Psoriasis Area Severity Index (PASI) score.Timepoint: Assessments will be done before and after treatment and changes will be noted.

Countries

India

Contacts

Public ContactDr Anup B Thakar
anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026